Pharma Surge
Pharma Surge
Intelligence Layer

News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

2x

daily refresh

Coverage

Latest indexed stories

8,237 stories indexed, page 51 of 138

🇺🇸Regulatoryfda.gov

FDA requires warning about rare but severe itching after stopping long-term use of oral allergy medicines cetirizine or levocetirizine (Zyrtec, Xyzal, and other trade names)

FDA requires warning about rare but severe itching after stopping long-term use of oral allergy medi...

FDA Drug ApprovalsOriginal source
🇺🇸Regulatoryfda.gov

FDA adds warning about serious risk of heat-related complications with antinausea patch Transderm Scōp (scopolamine transdermal system)

The antinausea patch Transderm Scōp (scopolamine transdermal system) can increase body temperature a...

FDA Drug ApprovalsOriginal source
🇺🇸Regulatoryfda.gov

FDA is requiring opioid pain medicine manufacturers to update prescribing information regarding long-term use

FDA is requiring safety labeling changes for opioid pain medicines to further emphasize and characte...

FDA Drug ApprovalsOriginal source
🇺🇸Regulatoryfda.gov

FDA removes risk evaluation and mitigation strategy (REMS) program for the antipsychotic drug Clozapine

FDA removes risk evaluation and mitigation strategy (REMS) program for the antipsychotic drug Clozap...

FDA Drug ApprovalsOriginal source
🇺🇸Regulatoryfda.gov

FDA to recommend additional, earlier MRI monitoring for patients with Alzheimer’s disease taking Leqembi (lecanemab)

FDA to recommend additional, earlier MRI monitoring for patients with Alzheimer’s disease taking Leq...

FDA Drug ApprovalsOriginal source
🇺🇸Regulatoryfda.gov

FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications

FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor...

FDA Drug ApprovalsOriginal source
🇺🇸Regulatoryfda.gov

FDA Is Requiring Warning about Vitamin B6 Deficiency and Associated Seizures for Drug Products Containing Carbidopa/Levodopa

FDA has notified application holders for all drug products containing carbidopa/levodopa that the Ag...

FDA Drug ApprovalsOriginal source
🇺🇸Regulatoryfda.gov

FDA Identifies Cases of Serious Liver Injury in Patients Taking Tavneos (avacopan) for Severe Active Anti-neutrophil Cytoplasmic Autoantibody (ANCA)-associated Vasculitis

FDA Identifies Cases of Serious Liver Injury in Patients Taking Tavneos (avacopan) for Severe Active...

FDA Drug ApprovalsOriginal source
🇺🇸Regulatoryfda.gov

Generic Drug User Fee Amendments

This page features news and information for industry and stakeholders about GDUFA, its fee structure...

FDA Drug ApprovalsOriginal source
🇺🇸Regulatoryfda.gov

As They Grow: Teaching Your Children How To Use Medicines Safely

How to start talking to your children about medicines and how you make medicine decisions for yourse...

FDA Drug ApprovalsOriginal source
🇺🇸Regulatoryfda.gov

FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan)

Stay informed on FDA updates and press announcements about recalls involving angiotensin II receptor...

FDA Drug ApprovalsOriginal source
🇺🇸Regulatoryfda.gov

Stop - Learn - Go: Tips for Talking with Your Pharmacist to Learn How to Use Medicines Safely

Points to discuss with your pharmacist and other healthcare providers

FDA Drug ApprovalsOriginal source
🇺🇸Regulatoryfda.gov

FDA Rare Disease Innovation Hub

FDA created the Rare Disease Innovation Hub (the Hub) to serve as a point of collaboration and conne...

FDA Drug ApprovalsOriginal source
🇺🇸Regulatoryfda.gov

FDA Issues Draft Guidance for Industry on the Design and Evaluation of Comparative Analytical Studies for Biosimilarity

CDER Statement

FDA Drug ApprovalsOriginal source
🇺🇸CROmedidata.com

Lee Shapiro on Data-driven Preventative Medicine and the Fight against “Sick Care”

Medidata SolutionsOriginal source
🌍Regulatorybasg.gv.at

Cinglan 30 mg-Filmtabletten

Rückruf aufgrund verminderter Wirkstofffreisetzung

BASG AustriaOriginal source
🇬🇧Researchpubmed.ncbi.nlm.nih.gov

Intravenous immunoglobulin treatment for long COVID: a case report of clinical and immunological findings

PubMed Lancet Infectious Diseases RSSOriginal source
🇬🇧Researchpubmed.ncbi.nlm.nih.gov

The case for routine patient review in long COVID research

PubMed Lancet Infectious Diseases RSSOriginal source
🇺🇸Researchpubmed.ncbi.nlm.nih.gov

Erratum: Tissue-Free Circulating Tumor DNA Assay and Patient Outcome in a Phase III Trial of FOLFOX-Based Adjuvant Chemotherapy (Alliance N0147)

PubMed Journal of Clinical Oncology RSSOriginal source
🌍Mediaseqens.com

SEQENS to launch PeptiCode™ HP-9: the first European biotech Hexapeptide-9

SeqensOriginal source
🌍Industrymenicon.com

Menicon Renames Its Sales Subsidiaries in Malaysia and Indonesia – Promoting Brand Integration and Business Expansion in Southeast Asia –

MeniconOriginal source
🌍Industryicecure-medical.com

Join IceCure at ASBrS 2026: Cryoablation for Breast Cancer in Low-Risk Patients

IceCure MedicalOriginal source
🌍CROtrinetx.com

Regeneron Collaborates with TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions

TriNetXOriginal source
🇺🇸CROppd.com

Preclarus lab data ecosystem: Delivering complete visibility and confidence across every lab partner

Thermo Fisher PPDOriginal source
🇯🇵CROen.cmicgroup.com

CMIC HOLDINGS Announces Changes to Management Structure

CMIC Group JapanOriginal source
🇺🇸CDMOkbibiopharma.com

KBI Biopharma Named Fill-Finish CDMO of the Year and Best in Class for Cultural Fit in 2026 CDMO Leadership Awards

KBI BiopharmaOriginal source
🇬🇧Researchstgeorges.nhs.uk

Health Chief Warns of “Triple Trouble” as doctors’ strike follows Easter holiday

St George's University HospitalsOriginal source
🇺🇸CROcaidya.com

From Data to Compliance: Key Elements of IMPD and CTA Preparation

Caidya (Clinipace)Original source
🇺🇸Industryinvestors.abeonatherapeutics.com

Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York

Abeona TherapeuticsOriginal source
🇬🇧Researchuclh.nhs.uk

UCLH recruits first European participant to advanced-phase lung cancer trial

University College London Hospitals (UCLH)Original source
🌍Industrysignanthealth.com

Signant Health Appoints Dr. Graham C. Ellis as Clinical Vice President

Signant HealthOriginal source
🇬🇧Researchstemcells.cam.ac.uk

Research from Rowitch and collaborators uncovers vulnerable brain cells prone to DNA damage in development and Multiple Sclerosis (MS)

Cambridge Stem Cell InstituteOriginal source
🇩🇪Researchuk-essen.de

Prof. Rüdiger Zimmerer übernimmt Leitung der MKG-Klinik an der Universitätsmedizin Essen

Universitätsklinikum EssenOriginal source
🇮🇹Researchhumanitas-research.com

The tumor microbiota: a new frontier in cancer biology

Humanitas Research Hospital (Milan)Original source
🇬🇧Researchuclh.nhs.uk

Resident doctor industrial action

University College London Hospitals (UCLH)Original source
🇸🇬Regulatoryapacmed.org

Advancing Value‑Based Healthcare (VBHC) for MedTech in the Asia‑Pacific Region

APACMedOriginal source
🇯🇵Researchkyoto-u.ac.jp

Kyoto University and JICA Kansai Center sign Japan's first MoUs for "JOCV (Science and Technology Research Cooperation)"

Kyoto UniversityOriginal source
🌍Industryicecure-medical.com

Discover IceCure Breast Cryoablation at ECIO 2026: Join us at the European Conference on Interventional Oncology in Basel

IceCure MedicalOriginal source
🇺🇸Industrycsafeglobal.com

When the Unexpected Happens: Cold Chain Disruption Case Study | Active vs Passive Pharma Shipping

CSafe GlobalOriginal source
🇯🇵Industrynippon-shinyaku.co.jp

入社式「社長メッセージ(要旨)」について

Nippon Shinyaku NewsOriginal source
🌍Industryorthofix.com

Behind the Scenes with R&D: Developing OsteoCove™

OrthofixOriginal source
🇺🇸Industrybambusatx.com

Bambusa Therapeutics Presented Positive Results from the Phase 1 Multiple Ascending Dose Trial of BBT001 at the 2026 American Academy of Dermatology (AAD) Annual Meeting

Bambusa TherapeuticsOriginal source
🇺🇸Devicesapyxmedical.com

Renuvion Wins 2026 NewBeauty Award For “Best Minimally Invasive Skin Tightner”

Apyx MedicalOriginal source
🇩🇪Mediacharite.de

Medizin der Zukunft: Die Charité im Wissenschaftsjahr 2026

Charité - Universitätsmedizin Berlin (EN)Original source
🌍Industrytizianalifesciences.com

Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging

Tiziana Life SciencesOriginal source
🌍CROtrinetx.com

Accelerating Study Design Decisions with Real‑World Data

TriNetXOriginal source
🌍Industryalloytx.com

Alloy Therapeutics Appoints Alexander Titus, Ph.D., to Lead New Vigilance Division Focused on Biosecurity and Rapid Therapeutic Response

Alloy TherapeuticsOriginal source
🌍Mediavalneva.com

Opportunities and Challenges of Being a Dual-Listed Company

ValnevaOriginal source
🌍Regulatorypharmac.govt.nz

Pharmac widens access to two melanoma medicines

Pharmac New ZealandOriginal source
🌍Industrymenicon.com

Menicon Appoints Oxana Pastushenko as CEO EMEA

MeniconOriginal source
🇯🇵Researchmed.kyoto-u.ac.jp

Prof. Ichiro Tateya has taken up his post in the Otolaryngology-Head and Neck Surgery

Kyoto University Faculty of MedicineOriginal source
🇯🇵Researchmed.kyoto-u.ac.jp

Prof. Kazuto Yoshimi has taken up his post in the Institute of Laboratory Animals

Kyoto University Faculty of MedicineOriginal source
🇯🇵Devicessysmex.co.jp

Completion of the Acquisition (Subsidiarization) of JEOL’s Clinical Chemistry Testing Business

Sysmex (Global)Original source
🇯🇵Industrysanten.com

Santen to Launch of UPNEEQ® Mini Ophthalmic Solution 0.1%, a Treatment for Acquired Blepharoptosis

Santen PharmaceuticalOriginal source
🇯🇵Researchkyoto-u.ac.jp

News Published on 2026/04/01 タグ Industry-Academia-Government Collaboration KyotoU, Kyoto International School conclude MoU for cooperation

Kyoto UniversityOriginal source
🌍Industryaptose.com

Aptose Biosciences Announces Results of Special Shareholders Meeting; Announces Receipt of Final Court Approval of Plan of Arrangement; Reports Year End 2025 Results and Corporate Highlights

Aptose BiosciencesOriginal source
🇺🇸Industrybiomarin.com

Bridget Yates on the Power of Purpose: Cultivating Impact Through Scientific Discovery

BioMarin PharmaceuticalOriginal source
🌍Researchunityhealth.to

Unity Health Toronto’s March Honour Roll

St. Michael's Hospital (Toronto)Original source
🌍Industryeledon.com

Diabetes patients CURED of disease with groundbreaking new treatment, study shows

Eledon PharmaceuticalsOriginal source